The goal of this demonstration project or observational study is to evaluate the feasibility and acceptability of a pharmacist-managed cabotegravir long acting injectable for PrEP program in a community pharmacy setting. The main question it aims to answer are: * Is the program feasible and acceptable at the end of 1 year of operations? * What are the facilitators and barriers of the program? Participants who want to start the FDA approved cabotegravir long acting injectable medication for PrEP will have the option participating in surveys and a review of their electronic health records. Medication will be administered based on FDA approved labeling guidelines and their PrEP care will be part of standard of care per CDC. Pharmacists who want to provide the service to their patients will have the option of participating in surveys pre and post implementation.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Percentage of participants recruited in PrEP care
Timeframe: initiation
Percentage of participants retained in PrEP care
Timeframe: 1 year
Adherence rate
Timeframe: 1 year
Age
Timeframe: initiation
Percentage Sex assigned at birth
Timeframe: initiation
Percentage of people with Gender identity
Timeframe: initiation
Percentage of people in a certain race
Timeframe: initiation
Percentage of people who identify in a certain ethnicity
Timeframe: initiation
Percentage of people with Insurance
Timeframe: 1 year
Percentage of people who have housing
Timeframe: 1 year
Percentage of people who have a primary care provider
Timeframe: initiation of study
Percentage of people with more than 1 sexual partner
Timeframe: initiation
Percentage of people with HIV positive sexual partner
Timeframe: initiation
Percentage of people who have inconsistent condom use during sex
Timeframe: initiation
Percentage of people who use injection drugs
Timeframe: initiation
Percentage of people who use HIV post exposure prophylaxis (PEP) in the last 12 months
Timeframe: initiation
Percentage of people who have a history of sexually transmitted infection in the previous 6 months
Timeframe: initiation
Percentage of people of certain background characteristics
Timeframe: initiation
Percentage of people with risk of acquiring HIV at initiation
Timeframe: 1 year
Percentage of people who are acceptable to cabotegravir long acting injectable for PrEP
Timeframe: initiation
Percentage of people feeling satisfied with cabotegravir long acting injectable for PrEP
Timeframe: 1 year
Percentage of people who discontinue long acting cabotegravir for PrEP for a particular reason
Timeframe: discontinuation
Percentage of Pharmacist providers who have certain attitudes to providing long acting cabotegravir for PrEP
Timeframe: at initiation
Percentage of pharmacist providers who are acceptable to providing long acting cabotegravir for PrEP
Timeframe: 6 months